Human endogenous retroviruses env gene expression and long terminal repeat methylation in colorectal cancer patients.


Journal

Medical microbiology and immunology
ISSN: 1432-1831
Titre abrégé: Med Microbiol Immunol
Pays: Germany
ID NLM: 0314524

Informations de publication

Date de publication:
Apr 2020
Historique:
received: 26 03 2019
accepted: 30 01 2020
pubmed: 11 2 2020
medline: 30 12 2020
entrez: 11 2 2020
Statut: ppublish

Résumé

Human endogenous retroviruses (HERV) are remnants of exogenous retroviral infections, representing 8% of the human genome. Their regulation is based on the DNA methylation of promoters, the long terminal repeats (LTRs). Transcripts from HERV have been associated with cancers, but reports concerning HERV expression in colorectal cancer remain sporadic. Sixty-three patients with advanced stages of colorectal cancer were enrolled in this study. The expressions of HERV env gene, and HERV-H, -K, -R and -P LTRs and Alu, LINE-1 methylation levels, were investigated in the tumor, normal adjacent tissues, and, where possible, blood and plasmatic extracellular vesicles (EVs). Associations among HERV env expression, methylation status and clinical characteristics were evaluated. No differences were observed in HERV env gene expression levels among the clinical specimens, while Alu, LINE-1, HERV-H and -K LTRs were demethylated in the tumor compared to the normal adjacent tissues (p < 0.05).The HERV env gene was expressed in the EVs at of 54% (-H), 38% (-K), 31% (-R) patients. Association was not found between HERV env expression and LTR methylation, but significant higher expression of HERV-P and -R env was found in tumor tissues arising from the right colon. Our findings do not demonstrate significant overexpression of the studied HERV in colorectal cancer, but their association with tumor localization and specificity of the changes in DNA methylation of retroelements are shown. HERV sequences were packaged in the EVs and might be transferred from one cell to another.

Identifiants

pubmed: 32040616
doi: 10.1007/s00430-020-00662-6
pii: 10.1007/s00430-020-00662-6
doi:

Substances chimiques

Gene Products, env 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

189-199

Subventions

Organisme : Ministero dell'Istruzione, dell'Università e della Ricerca
ID : 2015w729wh
Organisme : Università degli Studi di Milano
ID : PSR 2017-2018

Références

Nat Rev Genet. 2002 Jun;3(6):415-28
pubmed: 12042769
Clin Biochem Rev. 2010 May;31(2):31-8
pubmed: 20498827
Cell. 2015 Jan 15;160(1-2):48-61
pubmed: 25594174
Exp Cell Res. 2009 Mar 10;315(5):849-62
pubmed: 19167380
Drugs. 2018 Jun;78(8):789-798
pubmed: 29790124
Exp Mol Pathol. 2015 Jun;98(3):375-81
pubmed: 25445497
J Virol. 2001 Dec;75(23):11709-19
pubmed: 11689652
Gastroenterology Res. 2018 Aug;11(4):264-273
pubmed: 30116425
Carcinogenesis. 2014 Sep;35(9):2074-83
pubmed: 24858205
Retrovirology. 2017 Mar 22;14(1):21
pubmed: 28330477
Int J Mol Med. 2013 Oct;32(4):755-62
pubmed: 23900638
Proc Natl Acad Sci U S A. 1999 Jul 20;96(15):8681-6
pubmed: 10411935
Int J Mol Sci. 2016 Dec 27;18(1):
pubmed: 28035987
Mol Cells. 2009 Aug 31;28(2):99-103
pubmed: 19669627
Retrovirology. 2004 Oct 11;1:32
pubmed: 15476554
Oncotarget. 2015 Nov 24;6(37):40095-111
pubmed: 26517682
Biochem Biophys Res Commun. 2009 May 1;382(2):468-72
pubmed: 19289097
Arch Virol. 2008;153(8):1587-91
pubmed: 18604468
Br J Cancer. 1999 Jul;80(9):1312-21
pubmed: 10424731
J Gen Virol. 2011 Oct;92(Pt 10):2356-2366
pubmed: 21697344
Cell. 1990 Jun 1;61(5):759-67
pubmed: 2188735
Annu Rev Genomics Hum Genet. 2006;7:149-73
pubmed: 16722807
Nucleic Acids Res. 2006 Mar 22;34(6):e46
pubmed: 16554552
Neurology. 2007 May 29;68(22):1944-6
pubmed: 17536052
APMIS. 2016 Jan-Feb;124(1-2):140-9
pubmed: 26818268
Retrovirology. 2018 Aug 20;15(1):57
pubmed: 30126415
Biomed Res Int. 2015;2015:164529
pubmed: 25734056
Nucleic Acids Res. 2010 Apr;38(7):2229-46
pubmed: 20053729
J Clin Pathol. 2014 Sep;67(9):840-4
pubmed: 25016529
Melanoma Res. 2014 Oct;24(5):480-7
pubmed: 25026000
Cell. 2013 Mar 28;153(1):38-55
pubmed: 23540689
Nat Commun. 2011 Feb 01;2:180
pubmed: 21285958
Nature. 2012 Jul 18;487(7407):330-7
pubmed: 22810696
Int J Cancer. 2014 Feb 1;134(3):587-95
pubmed: 23873154
Cell Mol Life Sci. 2008 Nov;65(21):3366-82
pubmed: 18818873
PLoS One. 2012;7(1):e29950
pubmed: 22238681
Curr Colorectal Cancer Rep. 2015 Dec 1;11(6):408-413
pubmed: 26997937
Cancer Immun. 2004 Feb 11;4:2
pubmed: 14871062
Cancer Immun. 2008 Jun 27;8:11
pubmed: 18581998
Int J Cancer. 2005 Oct 10;116(6):914-9
pubmed: 15856472
Genome Biol Evol. 2013;5(2):307-28
pubmed: 23338945
J Natl Cancer Inst. 2008 Dec 3;100(23):1734-8
pubmed: 19033568
Nat Genet. 2006 Jul;38(7):787-93
pubmed: 16804544
J Biol Chem. 2012 Dec 21;287(52):43565-72
pubmed: 23118232
Clin Cancer Res. 2013 Nov 15;19(22):6112-25
pubmed: 24081977

Auteurs

Maria Dolci (M)

Department of Biomedical, Surgical and Dental Sciences, University of Milan, Via Carlo Pascal, 36, 20133, Milan, Italy.

Chiara Favero (C)

EPIGET - Epidemiology, Epigenetics and Toxicology Lab, Department of Clinical Sciences and Community Health, University of Milan, Via San Barnaba 8, Milan, Italy.

Letizia Tarantini (L)

Department of Preventive Medicine, Fondazione IRCSS Ca' Granda, Ospedale Maggiore Policlinico, Via San Barnaba 8, Milan, Italy.

Sonia Villani (S)

Department of Biomedical, Surgical and Dental Sciences, University of Milan, Via Carlo Pascal, 36, 20133, Milan, Italy.

Marco Bregni (M)

Hematology Unit, ASST Valle Olona, Ospedale di Circolo di Busto Arsizio, Via Arnaldo da Brescia 3, Busto Arsizio, Italy.

Lucia Signorini (L)

Department of Biomedical, Surgical and Dental Sciences, University of Milan, Via Carlo Pascal, 36, 20133, Milan, Italy.

Alberto Della Valle (A)

General Surgery Unit, Istituto Clinico Città Studi, Via Jommelli 19, Milan, Italy.

Filippo Crivelli (F)

Pathology Unit, ASST Valle Olona, Ospedale di Circolo di Busto Arsizio, Via Arnaldo da Brescia 3, Busto Arsizio, Italy.

Sarah D'Alessandro (S)

Department of Biomedical, Surgical and Dental Sciences, University of Milan, Via Carlo Pascal, 36, 20133, Milan, Italy.

Pasquale Ferrante (P)

Department of Biomedical, Surgical and Dental Sciences, University of Milan, Via Carlo Pascal, 36, 20133, Milan, Italy.

Valentina Bollati (V)

EPIGET - Epidemiology, Epigenetics and Toxicology Lab, Department of Clinical Sciences and Community Health, University of Milan, Via San Barnaba 8, Milan, Italy.
Department of Preventive Medicine, Fondazione IRCSS Ca' Granda, Ospedale Maggiore Policlinico, Via San Barnaba 8, Milan, Italy.

Serena Delbue (S)

Department of Biomedical, Surgical and Dental Sciences, University of Milan, Via Carlo Pascal, 36, 20133, Milan, Italy. serena.delbue@unimi.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH